In a recent review conducted by the Food and Drug Administration (FDA), researchers have recommended the reclassification of marijuana from a Schedule I to a Schedule III substance. Currently, marijuana is classified in the same category as highly dangerous controlled substances such as heroin and LSD. However, the FDA's findings suggest that marijuana has a lower potential for abuse and is increasingly accepted for medical use in certain parts of the United States. The National Institute on Drug Abuse (NIDA) has also concurred with the FDA's review.
Schedule I substances are classified as having a high potential for abuse and no accepted medical use. Moving marijuana to Schedule III would recognize its potential therapeutic benefits and place it in a category alongside substances like codeine and ketamine, which have known medical applications.
